TechFlow news — On April 5, VitaDAO, a decentralized organization for life science research co-founded with support from Ethereum creator "Vitalik Buterin" (Vitalik), announced on Twitter that it is voting on whether to create a for-profit company to secure and distribute funding for longevity research. The company, named VitaTech, would operate as a subsidiary/affiliate of VitaDAO and use public funds to license longevity technologies developed at U.S. universities and support their ongoing development. Besides Vitalik, TRON founder Justin Sun has also previously provided strong support for VitaDAO.
In January this year, VitaDAO announced it had raised $4.1 million in funding from investors including Balaji Srinivasan, former Chief Technology Officer of Coinbase, and Pfizer Ventures, the investment arm of the world's largest pharmaceutical company, Pfizer—marking Pfizer’s first investment in the Web3 space. VitaDAO stated it will use these funds to further finance longevity research projects and a biotech startup scheduled to spin out of the DAO next year.
In October last year, Justin Sun donated to VitaDAO’s Longevity Prize Fund, making him the second-largest donor to the fund, behind only Ethereum founder Vitalik Buterin.
On this matter, Justin Sun previously stated: "Life is the most precious thing in the universe. Extending average human lifespan will bring changes to the world beyond our imagination. I hope to attract more blockchain entrepreneurs and Web3 enthusiasts to join us in advancing the exploration of human life sciences."
Add to Favorites
Share to Social Media
